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Abstract
Background: Oxidative stress contributes to both intraocular pressure regulation and glaucomatous neuropathy.
The systemic redox status (solitary determination) was examined in primary open-angle glaucoma (POAG) patients
with cataract and nonglaucomatous cataract patients. Cataract-matched group comparisons appear more precise in
the context of oxidative stress evaluation. The aim of this study was to establish if systemic oxidative status in
POAG patients was elevated compared with the cataract only subjects.
Methods: The study included patients with primary open angle glaucoma (POAG group, n = 30) and controls (non
POAG group, n = 25). Serum concentration of lipofuscine (LPS), malondialdehyde (MDA) and activity of total
superoxide dismutase (SOD), and its mitochondrial (Mn-SOD) and cystolic (Cu,Zn-SOD) isoform were measured.
Total oxidant state (TOS) and total antioxidant capacity (TAC) in blood were also evaluated.
Results: Significant increase of LPS (p = 0.0002) and MDA (p = 0.005) concentration was observed in glaucomatous
patients as compared with controls. Total SOD activity was significantly lowered in the glaucoma group (p = 0.003);
serum level of Mn-SOD was significantly lower in glaucoma patients (p = 0.048) however, Cu,Zn-SOD was not.
Glaucoma patients presented elevated mean TOS (p = 0.016). Both groups presented with comparable TAC.
Conclusion: Systemic redox balance of cataract patients was significantly altered in the course of glaucoma.
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Background
Glaucoma refers to several disorders having the same
clinical features. Characterized by progressive retinal
ganglion cell (RGC) and axon loss; glaucoma causes
damage to the optic nerve and results in gradual visual
field loss. Subsequently, this leads to irreversible blind-
ness. Despite well-developed diagnostic tools and rela-
tively efficient treatment, glaucoma still remains the
world’s leading cause of irreversible blindness. Glau-
comatous neuropathy may progress with elevated or
normal (arbitrarily estimated) intraocular pressure (IOP).
Therefore, elevated IOP, the main known risk factor for
glaucoma, is neither enough nor necessary to trigger
glaucomatous neuropathy. Research suggests a multifac-
torial etiology of glaucoma pathogenesis; nevertheless,
the trigger(s) initiating glaucomatous pathology still
remains unidentified. Primary glaucoma should not be
considered solely as an ocular pathology [1]. Data sug-
gests oxidative stress in glaucomatous disturbances do
not conflict with other observations but complements
mechanical, vascular, genetic and immunologic theories
in the pathogenesis of glaucoma. Oxidative stress
presumably plays an important role in increasing IOP,
producing trabecular meshwork alterations and promot-
ing neuronal cell death affecting retinal ganglion cells in
glaucoma [2, 3]. Furthermore, an increase in IOP is
understood to generate oxidative stress in retina [4].
POAG in the context of oxidative stress presents two
main front lines of oxidation and defense against oxida-
tive stress. The first front line in the anterior segment
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functions when UV and visible light are the main
resources of exogenous ROS, produced mostly in aqueous
humor. The second front line is in the well vascularized
posterior segment and functions when endogenous and
systematic ROS are delivered with blood [5]. Additionally,
there is an age-dependent increase in production of en-
dogenous free radicals and ROS. Therefore, both POAG
occurrence and age dependent systemic redox balance
deterioration presumably have common pathways.
In this research serum oxidative state represented by
oxidative degradation products (malonyl dialdehyde -
MDA, lipofuscine - LPS) and selected antioxidant en-
zymatic defense (total superoxide dismutase - SOD, and
its isoenzymes: Mn-SOD and Cu,Zn-SOD) were studied.
We also evaluated the oxidant and antioxidant status by
measurement of total oxidant status (TOS) and total
antioxidant capacity (TAC) respectively.
MDA, widely regarded as a marker of a peroxidative
damage to cell membranes, is induced by physical and/
or chemical oxidative stress. Nucci et al. demonstrated
that glaucoma patients had significantly higher levels of
serum and humor aqueous MDA as compared with non-
glaucomatous controls [6].
LPS - Lipofuscin (called age pigment) is a marker of
normal aging. Lipofuscin tends to accumulate through-
out life in post-mitotic cells, such as neurons and glia.
Dolman et al. in 1980 reported the presence of lipofus-
cin in the optic nerve [7]. The subsequent investigations
linked LPS accumulation with age-related disorders,
especially with POAG [8].
As previously reported, human and animal ocular
fluids and tissues contain one of the major antioxidant
enzymes - superoxide dismutase (SOD, EC1.15.1.1)
which plays a key role in protecting against oxidative
damage [9]. SOD activity alteration was previously
reported in aqueous humor of glaucoma patients [10].
The aim of this present research was to assess serum
oxidative stress in glaucoma/cataract patients compared
with cataract only controls.
Methods
The study protocol was approved by the Ethics Commit-
tee of School of Medicine in Katowice, Poland (permis-
sion number: KNW/0022/KB1/123/10) and adhered to
the tenets of the Declaration of Helsinki for experiments
involving human tissue and samples.
Participants
The POAG group was comprised only of Caucasians.
Only patients whose eye was scheduled for antiglauco-
matous drainage surgery due to progressive visual field
loss and whose target IOP was not reached pharmaco-
logically, was taken under analysis.
Patients with previous history of IOP over 23 mmHg
within the last 6 months before examination and on
sampling day were excluded. We set the threshold of
23 mmHg, arbitrary (21 mmHg + 10%). We presuppose,
IOP ≤ 23 mmHg is not yet in the acute phase of intraoc-
ular hypertension, and a limitation of 21 mmHg would
reduce our examined group. All patients presented
bilateral visual field defect.
The Controls group included Caucasians who were
scheduled for cataract surgery.
Sequential inclusion criteria both for POAG and for
the Controls group were as follows:
(1) no previous intrabulbar surgery, (2) between 65
and 75 years old, (3) best corrected visual acuity of 0.5
or better (Snellen’s charts) (4) no myopia or hyperopia
>3D (dioptres) (5) non-smokers, (6) no documented,
diagnosed, treated ophthalmic and organic diseases (only
treated arterial hypertension was accepted), (7) no
abnormalities in the routine preoperative laboratory tests
especially in C-reactive protein (CRP), complete blood count
(CBC) and differential, (8) body mass index (BMI) < 30.
Patients for examined groups were chosen, according
to above mentioned criteria, and from patients consecu-
tively admitted to The Cataract/Glaucoma Station of
The Department of Ophthalmology, Medical University
of Silesia for planned surgery.
Ophthalmic examination
Clinical evaluation of POAG included gonioscopy, de-
tailed ophthalmoscopy, central corneal thickness meas-
urement, tonometry (Goldmann’s, Haag-Streit, Bern,
Switzerland; 0.5% Alcaine) visual field examination
(Octopus 301 HS, Interzeag) and policlinic history ana-
lysis. The average IOP for each patient was determined
by three measurements (the day before admission, day
of admission and the day of surgery). All IOP measure-
ments were taken during morning hours (between 8 AM
and 11 AM). The IOP policlinic history (within the last
6 months) together with our measurements guided us to
exclude POAG patients in the acute IOP phase.
The patients were examined on the day of blood sample
collection.
Blood sample collection
Blood samples were collected into chemically clean tubes
to obtain serum. After coagulation samples were centri-
fuged at room temperature for 10 min at 3000 rpm, serum
was retracted and transferred into clean tubes for bio-
chemical analysis. Pending analysis, serum samples were
frozen at −80 ° C for further studies.
Electrophysiological Examination
The transient pattern electroretinogram (PERG) was
examined using Reti-Port equipment (Roland Consult,
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Germany). The study conditions were performed as per
the recommendations and standards of the ISCEV
(International Society for Clinical Electrophysiology of
Vision) [11]. Square checks with check size 30’, contrast
97%, reversal rate four reversals per second were used.
Two trials for each stimulus condition were obtained to
confirm reproducibility, 200 sweeps were collected and
averaged. Fiber electrodes as recording electrodes, gold-
cup as a reference, and ground electrodes were used.
The patients wore best optical correction for the
distance of examination (1 m). Implicit time (the time to
peak) and amplitude of the negative wave N95 (from the
peak of P50 to the trough of N95) were measured.
Biochemistry
Determination of superoxide dismutase activity (SOD, Mn-
SOD, Cu,Zn-SOD)
Oyanagui’s method [12] was used to measure the activity
of SOD in blood serum. In this method, xanthine
oxidase produces superoxide anions, which react with
hydroxylamine forming nitric ions. These ions react with
naphthalene diamine and sulfanilic acid generating a
colored product. Concentration of this product is pro-
portional to the amount of superoxide anions produced
and is negatively proportional to the activity of SOD.
Absorbance was measured using an automated Perkin
Elmer analyzer at a wavelength of 550 nm. The enzym-
atic activity of SOD was expressed in nitric units. The
isoenzymes of SOD, Mn-SOD and CuZn-SOD, were also
indicated using KCN as the inhibitor of the CuZn-SOD ac-
tivity. The activity of SOD is equal to one nitric unit (NU)
when it inhibits nitric ion production by 50%. Activities of
SOD in blood serum were expressed in NU/ml.
Determination of malondialdehyde (MDA) concentration
The product of lipid peroxidation - MDA was measured
fluorometrically as 2-thiobarbituric acid-reactive sub-
stance (TBARS) in blood serum according to Ohkawa
[13] with modifications. Samples were mixed with 8,1%
sodium dodecyl sulfate, 20% acetic acid and 0,8% 2-
thiobarbituric acid. After vortexing, samples were incu-
bated for 1 h at 950 C and butanol-pyridine 15:1 (v/v)
was added. The mixture was shaken for 10 min. and
then centrifuged. The butanol- pyridine layer was mea-
sured fluorometrically at 552 nm and 515 nm excitation
(Perkin Elmer, USA). TBARS values are expressed as
malondialdehyde (MDA) equivalents. Tetraethoxypro-
pane was used as the standard. Concentrations are given
in μmol/l plasma.
Determination of Total Oxidation Status (TOS)
Total oxidant status was measured according to Erel
[14] in blood serum. The assay is based on the oxidation
of ferrous ion to ferric ion in the presence of various
oxidant species in acidic medium. The change in color
of the ferric ion by xylenol orange was measured as a
change in absorbance at 560 nm. This process was
applied to an automated Perkin Elmer analyzer and cali-
brated with hydrogen peroxide. Data is shown in μmol/l.
Determination of Total Antioxidant Capacity (TAC)
Total antioxidant capacity was measured according to
Erel [15] in blood serum. In this colorimetric method,
radicals are generated and the antioxidant activity of
blood serum reduces radical formation. The change in
color of ABTS+ ions (2,2′-azinobis(3-ethylbenzothiazo-
line-6-sulfonate) was measured as the change in absorb-
ance at 660 nm. This method was conducted in an
automated Perkin Elmer analyzer calibrated with Trolox.
Data is shown in mmol/l.
Determination of lipofuscin concentration
In blood serum, the LPS concentration was determined
according to Jain [16]. Fluorescence was measured using
an LS45 spectrofluorimeter Perkin Elmer at wavelengths
of 360 nm (absorbance) and 440 nm (emission). Values
are presented as relative units (relative fluorescence lipid
extract, RF), where X corresponds to a fluorescence
solution of 0.1 mg/mL quinidine sulfate in 0.1 N sulfuric
acid.
Statistical
The statistical analysis was performed with a Statistica
package. The comparison between groups was performed
either with parametrical t-test or with non-parametrical
Mann-Whitney test if assumptions of a parametrical test
were not met.
Results
Baseline patient characteristics are summarized in
Table 1.
Only one eye per patient was included in the study.
Number of patients with IOP < =21 was 17 and with
IOP > 21 was 13.
No significant differences between groups in BMI was
recorded.
Serum concentration of malondialdehyde (MDA), the
indicator of lipid peroxidation was significantly raised in
the glaucoma group (1.16 μmol/l; SD: 0.54; 95% CI:
0.96–1.36) as compared with controls (0.757 μmol/l; SD:
0.13 95% CI: 0.70–0.81) p = 0.005 (Table 2).
The serum lipofuscin varied between compared pa-
tients (Table 2). In glaucomatous subjects the mean con-
centration of “age pigment” was elevated to 1636.27 RF;
SD: 325.03 95% CI: 1514.90–1757.64 while nonglauco-
matous participants were about 1298.84 RF; SD: 241.59
95% CI: 1201.26–1396.42 (p = 0.0002).
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As recorded, the first line of antioxidant defense repre-
sented by total SOD activity in POAG patients (17.48
NU/ml; SD: 3,12 95% CI: 16,3–18,6) was decreased as
compared with healthy controls (20,43 NU/ml; SD: 4,03
95% CI: 18,80–22,06) - Table 2. The differences reached
statistical significance (p = 0.003). When SOD isoform
activities were assessed separately significant diversifica-
tion of examined groups were noted only in mitochon-
drial SOD2 (Mn-SOD) (glaucoma: 8.61 NU/ml; SD: 2.04
vs controls: 10.59 NU/ml; SD: 3.49. p = 0.048) – Table 2.
The differences between compared groups in the mean
cytosolic SOD1 (Cu,Zn-SOD) activity failed to reach sig-
nificance (glaucoma: 8.87 NU/ml; SD: 2.44 vs controls:
9.84 NU/ml; SD: 2.20. p = 0.13).
No correlation between concentration of MDA (p =
0.29), LPS (p = 0.14), activity of total SOD (p = 0.4), Mn-
SOD (p = 0.2), Cu,Zn-SOD (p = 0.99), TOS (p = 0.45),
TAC (p = 0.23) and N95 amplitude was found.
Total oxidative state (TOS) showed intensification in
the glaucoma group as compared with controls
(22.81 μmol/l; SD: 26,44; 95% CI: 12,94–32,68 vs
8.08 μmol/l; SD: 5,82; 95% CI: 4,71–9,35; p = 0.016).
Total antioxidant capacity (TAC) was comparable in
examined patients (1.02 mmol/l; SD: 0,09; 95% CI: 0,98–
1,06 in controls and 1.03 mmol/l; SD: 0,19; 95% CI:
0,96–1,10 in glaucoma, p = 0.31).
Discussion
In this study, we found increased oxidative stress in
patients with primary glaucoma. Changes in redox state
were observed by enzymatic defense (SOD), accumula-
tion of oxidative stress products (LPS and MDA) and
total oxidant state.
Slightly different from previous experimental protocols,
we designed this study model to select from participants
scheduled for surgical procedures. Medical pre-operative
evaluation was conducted in the hospital, which provided
well-documented medical history of those involved in the
study as compared with e.g., policlinic research model(s).
Primary glaucoma is rather generalized than just an ocular
disorder. Therefore, we believe, to examine primary glau-
coma precisely, the general clinical condition of patients
should be carefully studied.
We have included patients with documented visual
field (VF) damage progression in the POAG group. Al-
though performed, visual field analysis of participants
was intentionally precluded. To evaluate glaucomatous
damage in the course of oxidative stress precisely, in our
study, we chose the transient pattern electroretinogram
(PERG). The PERG is less depended on lens opacifica-
tion than visual field examination. In glaucoma, both
PERG amplitude reduction and implicit time increase
have been reported in various studies, however the
implicit time increase is relatively small and amplitude
reduction have drawn the most interest. Results from ex-
perimental studies (primate model) indicate that PERG
amplitude reduction precede the development of signifi-
cant changes in the optic nerve head, and are related to
the degree of cupping and nerve fiber loss, and are not
diminished when IOP is reduced pharmacologically [17].
Therefore, for patient comparisons and RGC vitality
assessment PERG is more precise, and less dependent
on physician interpretation. Optic nerve diseases prefer-
entially affect N95 and its amplitude is decreased or
absent in optic atrophy [18]. In this current study, no
Table 2 Differences in oxidative stress markers between groups
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significant differences in the N95 implicit time between
the study groups were found. The N95 amplitude was
notably significantly lower in the POAG group than in
the control group, which reflects advanced glaucomat-
ous atrophic changes of the optic nerve. No correlation
between the N95 amplitude and serum level of analyzed
substances indicates that PERG does not reflect rapid
local changes in ganglion cells’ activity in the presence of
oxidative stress (Fig. 1).
Mittag et al. demonstrated the developing changes in
optic nerve atrophy experimentally in a rat glaucoma
model. Their research suggests ERG responses begin to
decline after 3 to 4 months of about 100% increase in
IOP [19].
As described, glaucomatous pathological processes
fluctuate over stable and progressive states [20]. Our
glaucoma group patients were scheduled for surgery due
to glaucomatous neuropathy exacerbation. Therefore,
our examined patients were presenting in the active
phase of neuropathy. The examined group of patients
presented with oscillating IOP around is upper limit and
comparable among themselves.
We decided to include patients presenting with cata-
ract in both the examined group and the control. Oxida-
tive stress has long been involved in the pathogenesis of
cataract [21]. As suggested by Nucci et al. [6], comparing
the age-matched and cataract-matched groups is more
precise in the context of oxidative stress.
Noteworthy to mention, we sampled one tube of blood
serum for the measurement of redox status, incidentally
selecting an instant of the glaucomatous process. Thus,
we should include this determination as a screening test.
On the other hand, we included this eye in the research
that revealed progressive neuropathy; this was assessed
with visual field and electrophysiology over the last
6 months.
We examined eyes with IOP less or equal to 23 mmHg
over the last 6 months. Thus, we assume that primary
oxidative stress delivered with blood has a remarkable
impact on the glaucomatous process than topical oxida-
tive stress: that could be produced by intraocular pressure
≤23 mmHg.
We intentionally analyzed only one eye per patient be-
cause the second eye in many cases was after intrabulbar
surgery (drainage or/and cataract) which could have add-
itional impacts on the glaucomatous process in this eye.
The serum concentration of lipofuscin in POAG was
significantly higher as compared with controls. Consid-
ered together with the research of Fernandez de Castro
et al. [8], when lipofuscin concentration was recorded
proportionally higher in the optic nerve of glaucomatous
subjects, this suggests the age-related lipopigment
involvement in the exacerbation of a glaucomatous neur-
opathy in the course of age-related POAG.
Significant increase in MDA serum concentration (al-
most two fold) corresponds with results as a marker of
oxidation degradation products evaluated in serum [22],
aqueous humor [23] and both, serum and humor [6],
erythrocytes [5] and even in the optic nerve head [24].
This supports that systemic pathological processes are
reflected in the glaucomatous eye, both by increasing
IOP and exacerbation of RGC death. It should be men-
tioned that lipid metabolism has an impact on the
amount of MDA formation, thus we have included pa-
tients with comparable body mass index into our study.
Activity of the total superoxide dismutase in our
research model was significantly decreased in glau-
comatous patients and corresponds with observations of
Engin et al. [22]. Presumably, this decrease results from
the depletion of the antioxidant defense system due to
long exposure of oxidative stress. Glaucomatous patients
in our research presented with exacerbated oxidative
stress as indicated by TOS differences between groups.
When focused on isoenzymes separately, only SOD2
presented significant deficiency. Emerging evidence sug-
gests that SOD2 (mitochondrial), not SOD1 has a pro-
tective role against neuronal cell death induced by
glutamate excitotoxicity and oxidative stress [24].
Finally, we collated our results with other previous ob-
servation regarding accumulation of MD, LPS and tSOD
activity in serum, aqueous humor, lamina cribrosa and
optic nerve of patients with POAG (Table 3).
In our study, the antioxidative reserves (TAC) were
comparable with controls and oxidative stress. TOS was
higher in glaucomatous participants. It should be recog-
nized that only some antioxidative enzymes could play a
key role in a glaucomatous pathology.
Fig. 1 Pattern ERG representative for subjects from control and
POAG group. Lowered N95 amplitude in eye with glaucomatous
neuropathy as compared with control. μV/div – microvolts per
division; ms/div – milliseconds per division
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Finally, the biggest limitations of present study should
be mentioned. This study model made it impossible to
compare progressing with nonprogressing glaucomatous
subjects in the context of oxidative stress. For such a
comparison, a long-term prospective study with detailed
monitoring of systemic and topic conditions is most
suitable. Examined groups are small. However, the re-
sults are encouraging enough for designing a larger
study. Groups were not genetically investigated.
Conclusion
Systemic redox balance of cataract patients was signifi-
cantly altered in the course of glaucoma.
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